Matzen, K.
Moelling, K., RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides, . 2007; 25:669; : Johnson, W.E., Assisted suicide for retroviruses, 2007; 25:643.Wittmer-Elzaouk, L.
Moelling, K., Retroviral self-inactivation in the mouse vagina, . 2009; 82:22.: Hütter, G., Transplantation of blood stem cells for HIV/AIDS?, 2009; 12:10.Faria, N.R.
HIV eipdemiology. The early spread and ignition of HIV-1 in human, 2014; 346:56.Temin, H.M. and Mizutani, S., RNA-dependent DNA polymerase in virions of Rous sarcoma virus,
1970; 226:1211.Mölling, K.
Association of viral RT with an enzyme degrading the RNA of RNA-DNA hybrids, 1971; 234:240.Moelling, K., RT and RNase H: In a murine virus and in both subunits of an avian virus,
975; 39:269.Moelling, K., Targeting the RNase H by rational drug design,
012;26:1983.Moelling, K.
Relationship retroviral replication and RNA interference, 006; 71:365.Simon, D.M. and Zimmerly, S., A diversity of uncharacterized RTs in bacteria,
008; 36:7219.Lampson, B.C., Inouye, M., and Inouye, S., Retrons, msDNA, bacterial genome,
. 2005; 110:491.Moelling, K. and Broecker F., The RT-RNase H: From viruses to antiviral defense,
2015; 1341:126.: Tisdale, M. Moelling, K., Mutations in the RNase H of HIV-1 infectivity, 1991; 72:59.Broecker, F., Andrae, K., and Moelling, K., Activation of HIV RNase H, suicide a novel microbicide?,
012; 28:1397.Song, J.J.
Structure of Argonaute and implications for RISC slicer, 2004; 305:1434.Malik, H.S. and Eickbush, T.H., RNase H suggests a late origin of LTR from TE,
2001; 11:1187.Crow, Y.J.
Jackson, A.P., Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutiѐre syndrome and mimic congenital viral brain infection. . 2006; 38:910.Cerritelli, S.M. and Crouch, R.J., Ribonuclease H: The enzymes in eukaryotes,
2009; 276:1494.Nowotny, M., Retroviral integrase superfamily: The structural perspective,
2009; 10:144.Arshan Nasir, A., Sun, F.-J., Kim, K.M., and Caetano-Anolles, G., Untangling the origin of viruses and their impact on cellular evolution,
. 2014; 1341:61. Greider, C.W. and Blackburn, E.H., A specific telomere terminal transferase, 1985; 43:405.Skloot, R.,
(Crown Publishing Group, 2010).Nandakumar, J. and Cech, T.R., Finding the end: Recruitment of telomerase,
2013; 14:69.Budin, I. and Szostak, J.W., Transition from primitive to modern cell membranes,
011; 108:5249.Yeatman, T.J. and Roskoski, R. Jr., A renaissance for SRC,
2004; 4: 470.: Donner, P., Greiser-Wilke, I. and Moelling, K., Nuclear localization and DNA binding of Myc, 1982; 296:262 and Moelling, K. 1984, 312:551, Myb, 1985; 40:983.Axel, R., Schlom, J., and Spiegelman, S., Presence in human breast cancer of RNA homologous to MMTV
1972; 235:32. Moelling, K. Serine–threonine PK activities of Mil/Raf, 1984; 312:558.Zimmermann, S. and Moelling, K., Phosphorylation and regulation of Raf by Akt,
1999; 286:1741.Rommel, C.
Differentiation specific inhibition of Raf-MEK-ERK by Akt, 1999; 286:1738.Zimmermann, S., Moelling K., and Radziwil, G., MEK1 mediates positive feedback on Raf,
1997; 15:1503.Dummer, R. and Flaherty, K.T., Resistance with tyrosine kinase inhibitors in melanoma,
. 2012; 24:150.Das Thakur, M.,
Modelling Vemurafenib resistance in melanoma, 2013; 494:251.Holderfield, M.
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond, 2014; 14:455.McMahon, M., Parsing out the complexity of RAF inhibitor resistance,
. 2011; 24:361.Sun, C.
Bernards, R., Reversible resistance to BRAF(V600E) inhibition in melanoma, 2014; 508:118.: Liu, J. and Levens, D., Making Myc, . 2006; 302:1.: Gateff E: Malignant neoplasms of genetic origin in Drosophila, 1978; 200:1448.Sherr, C.J. and McCormick, F., The RB and p53 pathways in cancer.
2002; 2:103.Yi, L.
Multiple roles of p53 in somatic and stem cell differentiation, . 2012; 72:563.Wang, T.
Retroviruses shape the transcriptional network of p53. 007; 104:18613.: Baumgartner, M. Moelling, K., SRC-migration and invasion by PDZ, 008; 28:642.